{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:01:42Z","timestamp":1771466502511,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.7759\/cureus.25586","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T05:11:15Z","timestamp":1654146675000},"source":"Crossref","is-referenced-by-count":2,"title":["Hypertensive Anaphylaxis After Moderna COVID-19 Vaccination: A Case Report"],"prefix":"10.7759","author":[{"given":"Yoshitaka","family":"Furuto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaya","family":"Nohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohisa","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Anaphylaxis guideline. Japanese Society of Allergology. (2014). Accessed: October 11, 2021: https:\/\/anaphylaxis-guideline.jp."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/all.12437","article-title":"Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology","volume":"69","author":"Muraro A","year":"2014","unstructured":"Muraro A, Roberts G, Worm M, et al.. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014, 69:1026-45. 10.1111\/all.12437","journal-title":"Allergy"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.1967","article-title":"Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US-December 14, 2020-January 18, 2021","volume":"325","author":"Shimabukuro TT","year":"2021","unstructured":"Shimabukuro TT, Cole M, Su JR. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US-December 14, 2020-January 18, 2021. JAMA. 2021, 325:1101-2. 10.1001\/jama.2021.1967","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.07.048","article-title":"Risk of anaphylaxis after vaccination in children and adults","volume":"137","author":"McNeil MM","year":"2016","unstructured":"McNeil MM, Weintraub ES, Duffy J, et al.. Risk of anaphylaxis after vaccination in children and adults. J Allergy Clin Immunol. 2016, 137:868-78. 10.1016\/j.jaci.2015.07.048","journal-title":"J Allergy Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"R\u00fcggeberg JU","year":"2007","unstructured":"R\u00fcggeberg JU, Gold MS, Bayas JM, et al.. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2007, 25:5675-84. 10.1016\/j.vaccine.2007.02.064","journal-title":"Vaccine"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.121.17316","article-title":"Stage III hypertension in patients after mRNA-based SARS-CoV-2 vaccination","volume":"77","author":"Meylan S","year":"2021","unstructured":"Meylan S, Livio F, Foerster M, Genoud PJ, Marguet F, Wuerzner G. Stage III hypertension in patients after mRNA-based SARS-CoV-2 vaccination. Hypertension. 2021, 77:e56-7. 10.1161\/HYPERTENSIONAHA.121.17316","journal-title":"Hypertension"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9030221","article-title":"Allergic reactions to current available COVID-19 vaccinations: pathophysiology, causality, and therapeutic considerations","volume":"9","author":"Kounis NG","year":"2021","unstructured":"Kounis NG, Koniari I, de Gregorio C, et al.. Allergic reactions to current available COVID-19 vaccinations: pathophysiology, causality, and therapeutic considerations. Vaccines (Basel). 2021, 9:10.3390\/vaccines9030221","journal-title":"Vaccines (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/all.14711","article-title":"Allergic reactions to the first COVID-19 vaccine: a potential role of polyethylene glycol?","volume":"76","author":"Cabanillas B","year":"2021","unstructured":"Cabanillas B, Akdis CA, Novak N. Allergic reactions to the first COVID-19 vaccine: a potential role of polyethylene glycol?. Allergy. 2021, 76:1617-8. 10.1111\/all.14711","journal-title":"Allergy"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7004e1","article-title":"Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021","volume":"70","year":"2021","unstructured":"Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021. MMWR Morb Mortal Wkly Rep. 2021, 70.125-9. 10.15585\/mmwr.mm7004e1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.0600","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine","volume":"325","author":"Shimabukuro T","year":"2021","unstructured":"Shimabukuro T, Nair N. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine. JAMA. 2021, 325:780-1. 10.1001\/jama.2021.0600","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12948-018-0083-x","article-title":"Importance of hypersensitivity in adverse reactions to drugs in the elderly","volume":"16","author":"Ventura MT","year":"2018","unstructured":"Ventura MT, Boni E, Cecere R, et al.. Importance of hypersensitivity in adverse reactions to drugs in the elderly. Clin Mol Allergy. 2018, 16:7. 10.1186\/s12948-018-0083-x","journal-title":"Clin Mol Allergy"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-006-0107-9","article-title":"Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication","volume":"15","author":"Lee MY","year":"2007","unstructured":"Lee MY, Yang MH, Liu JH, et al.. Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication. Support Care Cancer. 2007, 15:89-93. 10.1007\/s00520-006-0107-9","journal-title":"Support Care Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-016-2913-y","article-title":"Anaphylactic reactions presenting with hypertension","volume":"5","author":"Solmazgul E","year":"2016","unstructured":"Solmazgul E, Kutlu A, Dogru S, et al.. Anaphylactic reactions presenting with hypertension. Springerplus. 2016, 5:1223. 10.1186\/s40064-016-2913-y","journal-title":"Springerplus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.166550","article-title":"2005 American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care","volume":"112","year":"2005","unstructured":"2005 American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2005, 112.IV1-203. 10.1161\/CIRCULATIONAHA.105.166550","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnf.0000177642.89888.85","article-title":"The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment","volume":"28","author":"Isbister GK","year":"2005","unstructured":"Isbister GK, Buckley NA. The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. Clin Neuropharmacol. 2005, 28:205-14. 10.1097\/01.wnf.0000177642.89888.85","journal-title":"Clin Neuropharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1042\/CS20040364","article-title":"5-HT in systemic hypertension: foe, friend or fantasy?","volume":"108","author":"Watts SW","year":"2005","unstructured":"Watts SW. 5-HT in systemic hypertension: foe, friend or fantasy?. Clin Sci (Lond). 2005, 108:399-412. 10.1042\/CS20040364","journal-title":"Clin Sci (Lond)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2004.08.005","article-title":"Functions of 5-HT2A receptor and its antagonists in the cardiovascular system","volume":"104","author":"Nagatomo T","year":"2004","unstructured":"Nagatomo T, Rashid M, Abul Muntasir H, Komiyama T. Functions of 5-HT2A receptor and its antagonists in the cardiovascular system. Pharmacol Ther. 2004, 104:59-81. 10.1016\/j.pharmthera.2004.08.005","journal-title":"Pharmacol Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S48611","article-title":"Anaphylaxis avoidance and management: educating patients and their caregivers","volume":"7","author":"J\u00e4rvinen KM","year":"2014","unstructured":"J\u00e4rvinen KM, Celestin J. Anaphylaxis avoidance and management: educating patients and their caregivers. J Asthma Allergy. 2014, 7:95-104. 10.2147\/JAA.S48611","journal-title":"J Asthma Allergy"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12520","article-title":"Anaphylaxis and cardiovascular disease: therapeutic dilemmas","volume":"45","author":"Lieberman P","year":"2015","unstructured":"Lieberman P, Simons FE. Anaphylaxis and cardiovascular disease: therapeutic dilemmas. Clin Exp Allergy. 2015, 45:1288-95. 10.1111\/cea.12520","journal-title":"Clin Exp Allergy"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/96828-hypertensive-anaphylaxis-after-moderna-covid-19-vaccination-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:52Z","timestamp":1707507352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/96828-hypertensive-anaphylaxis-after-moderna-covid-19-vaccination-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.25586","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}